ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,767Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 2061

$1.4M Total Retail Price of All Prescriptions

Rank: 38 out of 2061

554 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 554 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 554 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 18,920 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 1,016 797 S3 1 10
FUROSEMIDE 796 584 2 6
OMEPRAZOLE 717 540 3 5
SIMVASTATIN 710 520 4 1
LEVOTHYROXINE SODIUM 653 540 5 3
LISINOPRIL 641 416 6 2
POTASSIUM CHLORIDE 591 387 7 16
METOPROLOL TARTRATE 529 361 8 7
AMLODIPINE BESYLATE 454 362 9 4
WARFARIN SODIUM 427 380 10 11
METFORMIN HCL 407 240 11 9
KLOR-CON M20 394 371 12 47
NAMENDA 381 379 13 37
ATORVASTATIN CALCIUM 331 219 14 8
DONEPEZIL HCL 321 319 15 24
GABAPENTIN 314 225 16 15
CITALOPRAM HBR 307 272 17 20
CLOPIDOGREL 287 266 18 29
NEXIUM 255 180 19 26
MIRTAZAPINE 239 222 20 46
ACTOS 239 188 20 140
ZOLPIDEM TARTRATE 227 131 22 23
TRAZODONE HCL 225 162 23 39
HYDROCHLOROTHIAZIDE 222 175 24 12
PLAVIX 212 195 25 49
DIVALPROEX SODIUM 210 195 26 74
TRAMADOL HCL 200 121 27 18
FAMOTIDINE 194 143 28 67
IBUPROFEN 190 107 29 90
AZITHROMYCIN 189 131 30 34
CLONIDINE HCL 187 116 31 52
SUCRALFATE 182 148 32 151
TAMSULOSIN HCL 181 159 33 30
LANTUS 174 114 34 48
METOPROLOL SUCCINATE 173 138 35 19
LYRICA 172 132 36 83
PROMETHAZINE HCL 168 113 R 37 119
OXYCODONE-ACETAMINOPHEN 167 114 S2 38 36
NOVOLOG 164 106 39 102
PANTOPRAZOLE SODIUM 157 116 40 45
TRIAMTERENE-HCTZ 153 115 41 38
KLOR-CON M10 142 142 42 125
SERTRALINE HCL 140 104 43 21
RANITIDINE HCL 136 104 44 53
PROAIR HFA 131 74 45 40
BYSTOLIC 131 40 45 130
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 90 47 27
CARVEDILOL 128 96 48 22
DIGOXIN 127 101 49 56
CYCLOBENZAPRINE HCL 124 30 R 50 78
GEMFIBROZIL 120 108 51 107
CELEBREX 120 92 51 91
FLUTICASONE PROPIONATE 119 92 53 43
POLYETHYLENE GLYCOL 3350 117 104 54 64
ROPINIROLE HCL 116 89 55 92
LIDODERM 116 109 55 106
RISPERIDONE 114 97 57 66
PRAVASTATIN SODIUM 113 111 58 14
ALENDRONATE SODIUM 112 96 59 25
EXELON 110 110 60 94
LACTULOSE 108 97 61 131
DIOVAN 107 57 62 41
CRESTOR 105 83 63 31
CARBIDOPA-LEVODOPA 105 100 63 97
LOSARTAN POTASSIUM 96 65 65 17
OXYBUTYNIN CHLORIDE ER 93 83 66 80
JANUVIA 88 30 67 51
PAROXETINE HCL 88 66 67 61
PIOGLITAZONE HCL 87 63 R 69 292
QUETIAPINE FUMARATE 86 77 70 72
CYMBALTA 85 49 71 59
ESCITALOPRAM OXALATE 85 37 71 77
ENALAPRIL MALEATE 84 43 73 75
DILTIAZEM 24HR ER 82 68 74 108
TIZANIDINE HCL 80 33 75 137
LEVOFLOXACIN 80 55 75 111
NYSTATIN 77 64 77 148
ATENOLOL 77 61 77 13
ALLOPURINOL 75 75 79 28
SINGULAIR 75 26 79 88
INSULIN SYRINGE 74 42 81 105
LIPITOR 72 56 82 70
FLUOXETINE HCL 71 42 83 73
AMITRIPTYLINE HCL 69 44 R 84 89
VENLAFAXINE HCL ER 68 64 85 109
ADVAIR DISKUS 67 30 86 57
TRICOR 67 47 86 128
DILTIAZEM HCL 67 62 86 243
DILTIAZEM 24HR CD 67 67 86 118
MELOXICAM 67 50 86 44
LOSARTAN-HYDROCHLOROTHIAZIDE 66 54 91 50
PREMARIN 65 22 R 92 251
OXYBUTYNIN CHLORIDE 64 62 93 121
SPIRIVA 62 50 94 63
ISOSORBIDE MONONITRATE ER 61 48 95 42
AMOX TR-POTASSIUM CLAVULANATE 61 49 95 113
SEROQUEL 60 57 97 157
IPRATROPIUM-ALBUTEROL 59 45 98 117
OXYCODONE HCL-ACETAMINOPHEN 59 46 S2 98 114
FENTANYL 59 30 S2 98 84
CARISOPRODOL 58 32 R 101 156
LANSOPRAZOLE 58 38 101 139
GLIMEPIRIDE 57 30 103 33
TRIAMCINOLONE ACETONIDE 56 45 104 172
CEFTRIAXONE 56 54 104 228
LEVETIRACETAM 56 55 104 102
SPIRONOLACTONE 55 54 107 62
ABILIFY 55 48 107 160
SODIUM CHLORIDE 55 45 107 192
PREDNISONE 54 45 110 32
METOCLOPRAMIDE HCL 54 46 110 138
DIPHENOXYLATE-ATROPINE 54 50 110 324
MONTELUKAST SODIUM 53 32 113 176
KLOR-CON 10 53 46 113 141
LANTUS SOLOSTAR 53 38 113 76
LOVASTATIN 51 34 116 35
CEPHALEXIN 51 40 116 112
ALPRAZOLAM 51 36 116 85
JANUMET 50 0 119 180
HYDROXYZINE PAMOATE 50 38 R 119 360
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.